The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
The purpose of this research is to test the effect of two digital health interventions on cardiovascular health and subclinical cardiac dysfunction in postpartum individuals after pregnancies complicated by new-onset hypertensive disorder of pregnancy (HDP). All participants will undergo echocardiography and have their blood pressure/weight captured at 3 months and 12 months postpartum. If randomized to the intervention arm, the participant will be given a subscription to a mobile health application and a digital blood pressure monitoring system, and asked to utilize these at home during the one year of the study along with usual care. If randomized to the control arm, the participant will receive care as usual.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
120
As a part of the bundled digital health intervention, the participant will receive instructions on how to follow a link in their electronic patient portal that will allow direct input of home blood pressure readings for clinical review.
As a part of the bundled digital health intervention, the participant will be given a lifestyle change mobile health application.
Northwestern University, Dept. of Cardiology
Chicago, Illinois, United States
RECRUITINGSystolic blood pressure
All participants will have systolic blood pressure measured at 3 months and 12 months postpartum
Time frame: 3 months postpartum; 12 months postpartum
Weight
All participants will have weight measured at 3 months and 12 months postpartum
Time frame: 3 months postpartum; 12 months postpartum
Subclinical cardiovascular dysfunction via echocardiography
All participants will have echocardiography performed at 3 months and 12 months postpartum to assess subclinical cardiovascular dysfunction
Time frame: 3 months postpartum; 12 months postpartum
Study feasibility
The investigators will assess study feasibility (% enrolled in digital health intervention) at the end of the study
Time frame: 12 months postpartum
Participant engagement
The investigators will assess participant engagement (% continuing to actively use digital health interventions) at the end of the study
Time frame: 12 months postpartum
Anti-hypertensive medication use (%)
The investigators will assess participant anti-hypertensive medication use (%) at 3 months and 12 months
Time frame: 3 months postpartum; 12 months postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.